Suppr超能文献

磷酸二酯酶 5 在人类和大鼠下尿路组织中的表达以及他达拉非对自发性高血压大鼠前列腺氧合作用的影响。

Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats.

机构信息

Department of Clinical Physiopathology, Sexual Medicine and Andrology Unit, University of Florence, Florence, Italy.

出版信息

J Sex Med. 2011 Oct;8(10):2746-60. doi: 10.1111/j.1743-6109.2011.02416.x. Epub 2011 Aug 3.

Abstract

INTRODUCTION

In humans, prostate phosphodiesterase type 5 inhibitors (PDE5) expression was prominently localized in the endothelial and smooth muscle cells of the vascular bed, suggesting a possible action of PDE5 inhibitors (PDE5i) on prostate blood flow.

AIM

To investigate PDE5 expression in human and rat lower urinary tract (LUT) tissues, including vasculature, and determine the effects of PDE5 inhibition with tadalafil on prostatic blood perfusion.

MAIN OUTCOME MEASURES

Human vesicular-deferential arteries (which originate from the inferior vesical artery, the main arterial source of blood supply to the bladder and prostate) were analyzed for PDE5 expression and activity. The effects of tadalafil on prostate oxygenation were studied in spontaneously hypertensive rats (SHR), characterized by ischemia/hypoxia of the genitourinary tract.

METHODS

PDE5 expression was evaluated by quantitative reverse transcription-polymerase chain reaction and immunohistochemistry. SHR were treated with tadalafil (2 mg/kg/day) for 1, 7, or 28 days and compared with untreated SHR and the unaffected counterpart Wistar-Kyoto (WKY) rats. Prostate oxygenation was detected by Hypoxyprobe-1 and hypoxia markers (hypoxia-inducible factor-1α[HIF-1α] and endothelin-1 type B [ETB]) immunostaining.

RESULTS

Human vesicular-deferential artery expressed high levels of PDE5, similar to corpora cavernosa, immunolocalized in the endothelial and smooth muscle layer. In these arteries, tadalafil inhibited cyclic guanosine monophosphate breakdown (half maximal inhibitory concentration (IC(50) ) in the low nanomolar range, as in corpora cavernosa) and increased the relaxant response to sodium nitroprusside. SHR prostate resulted markedly hypoxic (hypoxyprobe immunopositivity) and positive for HIF-1α and ETB, while tadalafil treatment restored oxygenation to WKY level at each time point. The mRNA expression of the HIF-1α target gene, BCL2/adenovirus E1B 19 kDa interacting protein 3, was significantly increased in SHR prostate and partially restored to WKY level by tadalafil.

CONCLUSION

Human vesicular-deferential artery is characterized by a high expression and activity of PDE5, which was inhibited by tadalafil in vitro. In SHR, tadalafil increases prostate tissue oxygenation, thus suggesting a possible mechanism through which PDE5i exert beneficial effects on LUT symptoms.

摘要

简介

在人类中,前列腺磷酸二酯酶 5 抑制剂(PDE5)的表达主要定位于血管床的内皮细胞和平滑肌细胞,提示 PDE5 抑制剂(PDE5i)可能对前列腺血流有作用。

目的

研究人类和大鼠下尿路(LUT)组织中 PDE5 的表达,包括脉管系统,并确定 PDE5 抑制作用对前列腺血流灌注的影响。

主要观察指标

分析来源于膀胱下动脉(供应膀胱和前列腺的主要动脉血液来源)的人膀胱前列腺动脉的 PDE5 表达和活性。研究 PDE5 抑制剂他达拉非对自发性高血压大鼠(SHR)的影响,其特点是泌尿生殖道缺血/缺氧。

方法

通过定量逆转录聚合酶链反应和免疫组织化学评估 PDE5 表达。用他达拉非(2mg/kg/d)处理 SHR 1、7 或 28 天,并与未处理的 SHR 和未受影响的对照 Wistar-Kyoto(WKY)大鼠进行比较。通过 Hypoxyprobe-1 和缺氧标志物(缺氧诱导因子-1α[HIF-1α]和内皮素-1 型 B [ETB])免疫染色检测前列腺氧合。

结果

人膀胱前列腺动脉表达高水平的 PDE5,类似于海绵体,免疫定位在血管内皮和平滑肌层。在这些动脉中,他达拉非抑制环鸟苷单磷酸分解(半数最大抑制浓度(IC50)在低纳摩尔范围内,与海绵体相同)并增加对硝普钠的舒张反应。SHR 前列腺明显缺氧(Hypoxyprobe 免疫阳性),HIF-1α 和 ETB 阳性,而他达拉非治疗在每个时间点均使前列腺氧合恢复到 WKY 水平。SHR 前列腺中 HIF-1α 靶基因 BCL2/腺病毒 E1B 19kDa 相互作用蛋白 3 的 mRNA 表达显著增加,他达拉非部分恢复至 WKY 水平。

结论

人膀胱前列腺动脉的特点是 PDE5 表达和活性高,他达拉非在体外抑制 PDE5。在 SHR 中,他达拉非增加前列腺组织氧合,提示 PDE5i 对 LUT 症状发挥有益作用的可能机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验